|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01498 PURAPHARM
Nominal 
0.640 0.000 (0.000%) | 2024/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2023/06 HKD(K$) | 2022/06 HKD(K$) | 2021/06 HKD(K$) | 2020/06 HKD(K$) | |
| Turnover | 207,627 | 6.431% | 195,081 | 230,760 | 302,757 | 280,432 |
| Cost of Sales | (94,365) | 13.479% | (83,156) | (80,655) | (106,353) | (115,598) |
| Gross Profit | 113,262 | 1.195% | 111,925 | 150,105 | 196,404 | 164,834 |
| 2024/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2023/06 HKD(K$) | 2022/06 HKD(K$) | 2021/06 HKD(K$) | 2020/06 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | 1,264 | -- | (46) | 2,060 | (3,221) | (3,734) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (149) | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | (14,765) | -59.563% | (36,514) | (34,699) | 17,386 | 16,388 | |
| Taxation | (3,921) | 237.726% | (1,161) | (5,204) | (5,412) | (4,951) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (18,686) | -50.402% | (37,675) | (39,903) | 11,974 | 11,437 | |
| 2024/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2023/06 HKD(K$) | 2022/06 HKD(K$) | 2021/06 HKD(K$) | 2020/06 HKD(K$) | |
| Net Finance Costs / (Income) | 12,942 | -0.934% | 13,064 | 13,730 | 13,428 | 10,669 |
| Depreciation & Amortisation | 21,696 | 1.459% | 21,384 | 28,308 | 28,250 | 24,992 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/06 | 2022/06 | 2021/06 | 2020/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/06 | 2022/06 | 2021/06 | 2020/06 | |
| EPS (cts) | -4.730 | -50.419% | -9.540 | -10.120 | 3.040 | 3.280 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 0.330 | -- | 0.546 | 0.894 | 1.335 | 1.184 |
| Remarks: | Real time quote last updated: 25/11/2024 09:39 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders ($) | HKD -18,686,000 |
| %Change | -50.402% |
| EPS / (LPS) | HKD -0.047 |
| NBV Per Share ($) | HKD 0.330 |